Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 38 páginas
Examen

UT Arlington NURS 5334 Advanced Pharmacology for NPs Final Exam (pdf) | 2026/2027 | Advanced Pharm Q&A | Pharmacology

Document preview thumbnail
Vista previa 4 fuera de 38 páginas

This document helps you master the NURS 5334 Advanced Pharmacology Final Exam at UT Arlington via targeted Q&A with detailed rationales. It covers comprehensive pharmacotherapeutics for advanced nursing practice—including pharmacokinetics, pharmacodynamics, antimicrobial therapy, and clinical drug management across cardiovascular, endocrine, respiratory, gastrointestinal, pain management, and dermatologic/musculoskeletal systems. Engineered to maximize retention and sharpen clinical decision-making for graduate-level nurse practitioners, this test pack simplifies complex pharmacology content, saving preparation time and ensuring you secure an A on your final assessment.

Vista previa del contenido

UT Arlington NURS 5334 Final Exam (pdf) | 2026/2027 | Advanced
Pharmacology for NPs Q&A | Pharmacology

1. Which of the following best defines pharmacokinetics?

A) The impact of drugs on the body

B) The impact of the body on drugs

C) The study of drug receptors

D) The study of drug adverse effects

Correct Answer: The impact of the body on drugs

Rationale: Pharmacokinetics is the study of drug movement throughout the
body, encompassing absorption, distribution, metabolism, and excretion
(ADME). It describes what the body does to the drug, as opposed to
pharmacodynamics, which describes what the drug does to the body.



2. Which pharmacokinetic process is primarily responsible for drug
bioavailability?

A) Absorption

B) Distribution

C) Metabolism

D) Excretion

Correct Answer: Absorption

Rationale: Bioavailability is the fraction of an administered dose of
unchanged drug that reaches systemic circulation. Absorption is the primary
determinant of bioavailability for non-IV routes.



3. A drug with a high volume of distribution (Vd) is most likely to:

A) Remain mostly in the plasma

B) Require dialysis for overdose removal

C) Accumulate in tissues

D) Have a short half-life

,Correct Answer: Accumulate in tissues

Rationale: High Vd indicates extensive tissue binding and uptake. Drugs with
large Vd (e.g., lipophilic drugs) are widely distributed throughout the body
and dialysis is ineffective for removal.



4. A patient is prescribed a drug that is a weak acid with a pKa of 4.4. In
which part of the gastrointestinal tract will absorption be most rapid?

A) Mouth (pH 7.0)

B) Stomach (pH 1.5)

C) Duodenum (pH 6.0)

D) Colon (pH 7.5)

Correct Answer: Stomach (pH 1.5)

Rationale: Weak acids are non-ionized (lipid-soluble) in acidic environments,
facilitating absorption across cell membranes. The stomach's acidic pH
promotes the non-ionized form of a weak acid, enhancing absorption.



5. A patient with chronic kidney disease (Stage 4) is prescribed a medication
that is primarily renally excreted. Which of the following dose adjustments is
most appropriate?

A) A higher dose to achieve a therapeutic effect

B) A lower dose or longer dosing interval to prevent toxicity

C) The same dose as a patient with normal renal function

D) An increased frequency of administration

Correct Answer: A lower dose or longer dosing interval to prevent toxicity

Rationale: In renal impairment, drug clearance is reduced, leading to drug
accumulation and increased risk of toxicity. Dose reduction or extended
dosing intervals are required to maintain safe therapeutic levels.



6. A drug has a half-life of 24 hours. Approximately how many hours will it
take for the drug to reach steady state?

,A) 24 hours

B) 48 hours

C) 120 hours

D) 240 hours

Correct Answer: 120 hours

Rationale: Steady state is achieved after approximately 4-5 half-lives. With a
half-life of 24 hours, 4-5 half-lives equal 96-120 hours.



7. Grapefruit juice inhibits CYP3A4. What effect would this have on felodipine
(a calcium channel blocker)?

A) Decreased effect

B) Increased toxicity

C) No change

D) Faster elimination

Correct Answer: Increased toxicity

Rationale: Grapefruit juice inhibits CYP3A4 in the intestinal wall and liver,
decreasing the metabolism of drugs like felodipine. This leads to increased
drug levels and potential toxicity.



8. A drug with zero-order kinetics is eliminated at:

A) A constant rate per unit time

B) A constant percentage per unit time

C) An increasing rate over time

D) A decreasing rate over time

Correct Answer: A constant rate per unit time

Rationale: Zero-order kinetics means a constant amount of drug is
eliminated per unit time, regardless of concentration. This is in contrast to
first-order kinetics, where a constant percentage is eliminated.

, 9. A patient with heart failure is prescribed digoxin. Which physiological
change associated with aging would most likely increase the risk of digoxin
toxicity?

A) Increased glomerular filtration rate

B) Decreased lean body mass

C) Increased hepatic blood flow

D) Decreased serum albumin

Correct Answer: Decreased serum albumin

Rationale: Aging is associated with decreased serum albumin. Digoxin is
moderately protein-bound. Lower albumin levels increase the free (active)
fraction of the drug, leading to a greater pharmacological effect and higher
risk of toxicity.



10. Which of the following is a potential adverse effect of long-term NSAID
use?

A) Hypotension

B) Gastrointestinal bleeding

C) Hypokalemia

D) Bronchodilation

Correct Answer: Gastrointestinal bleeding

Rationale: NSAIDs inhibit COX-1, which is protective of the gastric mucosa,
leading to an increased risk of gastrointestinal ulcers and bleeding.



11. A patient with a history of myocardial infarction is prescribed a beta-
blocker. Which of the following is a primary benefit of beta-blocker therapy
post-MI?

A) Increased cardiac output

B) Decreased myocardial oxygen demand

C) Increased heart rate

D) Bronchodilation

Información del documento

Subido en
13 de agosto de 2026
Número de páginas
38
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$15.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
ExamStudy
3.0
(1)
Vendido
8
Seguidores
0
Artículos
1067
Última venta
1 día hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes